This study exists to understand how blood tests and biological markers holds up over time after the earliest research stage. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Bergen

SchizophreniaDrugFrom 18 Years to 70 Years

Countries: Norway
Sponsor: Haukeland University Hospital
Condition: Schizophrenia

View study

TerminatedEUCTR 2017-000163-32

The Norwegian Prednisolone in Early Psychosis Study - NorPEPS The role of immune-modulating strategies in the treatment of psychosis

This study was terminated in Norway. It focuses on Schizophrenia.

In Norway

SchizophreniaOther

Countries: Norway
Sponsor: Helse-Bergen HF
Condition: Schizophrenia

View study

CompletedNCT04073862

The Norwegian Stepped-Care TF-CBT Study

This summary needs review. Please check the official study record and contact the research team for details.

In Oslo

PTSD, DepressionBehavioralFrom 7 Years to 12 Years

Countries: Norway
Sponsor: Norwegian Center for Violence and Traumatic Stress Studies
Condition: PTSD, Depression

View study

CompletedNCT02950376

The Novel Addiction Assessment Study in Synthetic Drugs Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai

AddictionOtherFrom 18 Years to 45 Years

Countries: China
Sponsor: Shanghai Mental Health Center
Condition: Addiction

View study

Active Not RecruitingNCT06475534

The Nuestros Días ("Our Days") Study

This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Birmingham

Anxiety, DepressionOtherFrom 18 Years to 100 Years

Countries: United States
Sponsor: University of Alabama at Birmingham
Condition: Anxiety, Depression

View study

CompletedNCT03810495

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

In New York

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Go Medical Industries Pty Ltd
Condition: Addiction

View study

CompletedNCT03167307

The Omega-3 Fatty Acid Paediatric Depression study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Liestal

DepressionDrugFrom 8 Years to 18 Years

Countries: Switzerland
Sponsor: Gregor Berger
Condition: Depression

View study

Active Not RecruitingNCT04916626

The OPUS YOUNG study. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

This study is looking at whether cognitive behavioural therapy can help people with depression or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In Hellerup

Schizophrenia, DepressionBehavioralFrom 12 Years to 17 Years

Countries: Denmark
Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition: Schizophrenia, Depression

View study

CompletedNCT00917397

The Outcome of Treatment of Traumatised Refugees With Psychotherapy and/or Antidepressants

This summary needs review. Please check the official study record and contact the research team for details.

In Hellerup

PTSDDrugFrom 18 Years to 65 Years

Countries: Denmark
Sponsor: Caecilie Buhmann
Condition: PTSD

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.